|
|||
Acute hepatitis B virus infection is a short-term illness that occurs within the first 6 months after someone is exposed to the hepatitis B virus. Acute infection can ? but does not always ? lead to chronic infection. Chronic hepatitis B virus infection is a long-term illness that occurs when the hepatitis B virus remains in a person?s body.
How common is chronic hepatitis B in the United States? In the United States, an estimated 800,000 to 1.4 million persons have chronic hepatitis B virus infection.
Birth (spread from an infected mother to her baby during birth) Sex with an infected partner Sharing needles, syringes, or other drug-injection equipment Sharing items such as razors or toothbrushes with an infected person Direct contact with the blood or open sores of an infected person Exposure to blood from needlesticks or other sharp instruments.
-Have sex with an infected person -Have multiple sex partners -Have a sexually transmitted disease -Are men who have sexual contact with other men -Inject drugs or share needles, syringes, or other drug equipment -Live with a person who has chronic hepatitis B -Are infants born to infected mothers -Are exposed to blood on the job -Are hemodialysis patients -Travel to countries with moderate to high rates of hepatitis B
-Fever -Fatigue -Loss of appetite -Nausea -Vomiting -Abdominal pain -Dark urine -Clay-colored bowel movements -Joint pain -Jaundice (yellow color in the skin or the eyes)
Hepatitis B Surface Antigen (HBsAg) is a protein on the surface of the hepatitis B virus. It can be detected in the blood during acute or chronic hepatitis B virus infection. The body normally produces antibodies to HBsAg as part of the normal immune response to infection. A positive test means: A person has an acute or chronic hepatitis B virus infection and can pass the virus to others A negative test means: A person does not have the hepatitis B virus in his or her blood
The hepatitis B vaccine series is a sequence of shots that stimulate a person?s natural immune system to protect against HBV. After the vaccine is given, the body makes antibodies that protect a person against the virus. An antibody is a substance found in the blood that is produced in response to a virus invading the body. These antibodies are then stored in the body and will fight off the infection if a person is exposed to the hepatitis B virus in the future.
-All infants, starting with the first dose of hepatitis B vaccine at birth -All children & adolescents younger than 19 years of age old who have not been vaccinated -People whose sex partners have hepatitis B -Sexually active persons not in a long-term, mutually monogamous relationship -Persons seeking evaluation or treatment for a sexually transmitted disease -Men who have sexual contact with other men -People who share needles, syringes, or other drug-injection equipment -People with close household contact with someone infected with hepatitis B -Healthcare and public safety workers at risk for exposure to blood or blood-contaminated body fluids on the job -People with end-stage renal disease, including predialysis, hemodialysis, peritoneal dialysis, and home dialysis patients -Residents and staff of facilities for developmentally disabled persons -Travelers to regions with moderate or high rates of hepatitis B -People with chronic liver disease -People with HIV infection -Anyone who wishes to be protected from hepatitis B virus infection In order to reach individuals at risk for hepatitis B, vaccination is also recommended for anyone in or seeking treatment from the following: -Sexually transmitted disease treatment facilities -HIV testing and treatment facilities -Facilities providing drug-abuse treatment and prevention services -Healthcare settings targeting services to injection drug users -Healthcare settings targeting services to men who have sex with men -Chronic hemodialysis facilities and end-stage renal disease programs -Correctional facilities -Institutions & nonresidential day care facilities for the developmentally disabled
All children should get their first dose of hepatitis B vaccine at birth and complete the vaccine series by 6?18 months of age. All children and adolescents younger than 19 years of age who have not yet gotten the vaccine should also be vaccinated. "Catch-up" vaccination is recommended for children and adolescents who were never vaccinated or who did not get the entire vaccine series. -The hepatitis B vaccine for Adults: Any adult who is at risk for hepatitis B virus infection or who wants to be vaccinated should talk to a health professional about getting the vaccine series. SOURCE: Centers for Disease Control and Prevention (CDC) www.cdc.gov |
| Bookmarks |
| Thread Tools | |
| Display Modes | |
|
|